Sensitivity of direct immunofluorescence in oral diseases : study of 125 cases by Sano, Susana Mariela et al.
E287
Med Oral Patol Oral Cir Bucal. 2008 May1;13(5):E287-91.                                                                                                                                                                    Sensitivity of direct immunofluorescence                                                                            Med Oral Patol Oral Cir Bucal.  2008 May1;13(5):E287-91.                                                                                                                                                                 Sensitivity of direct immunofluorescence
Sensitivity of direct immunofluorescence in oral diseases. Study of 125 cases
Susana Mariela Sano 1, María Cecilia Quarracino 2, Silvia Cristina Aguas 3, Ernestina Jesús González 1, Laura Harada 4, 
Hugo Krupitzki 5, Ana Mordoh 6
(1) Odontóloga, docente Cátedra de Patología y Clínica Bucodental II, Facultad de Odontología, Universidad de Buenos Aires, 
Argentina
(2) Profesora Adjunta Cátedra de Patología y Clínica Bucodental II, Facultad de Odontología, Universidad de Buenos Aires, Ar-
gentina
(3) Dra. en Odontología, Profesora Adjunta Cátedra de Patología y Clínica Bucodental II, Facultad de Odontología, Universidad 
de Buenos Aires, Argentina
(4) Odontóloga, jefe de trabajos prácticos Cátedra de Patología y Clínica Bucodental II, Facultad de Odontología, Universidad de 
Buenos Aires, Argentina
(5) Médico, Dirección de Investigación – CEMIC
(6) Médica Dermatóloga, docente Cátedra de Patología y Clínica Bucodental II, Facultad de Odontología, Universidad de Buenos 
Aires, Argentina
Correspondence:
Dr. Susana Mariela Sano
Facultad de Odontología Universidad de Buenos Aires
Marcelo T. de Alvear 2124
Cátedra de Patología y Clínica Bucodental II - 5º piso sector A





Sano SM, Quarracino MC, Aguas SC, González EJ, Harada L, Kru-
pitzki H, Mordoh A. Sensitivity of direct immunofluorescence in oral 
diseases. Study of  125 cases. Med Oral Patol Oral Cir Bucal. 2008 
May1;13(5):E287-91.
© Medicina Oral S. L. C.I.F. B 96689336 - ISSN 1698-6946
http://www.medicinaoral.com/medoralfree01/v13i5/medoralv13i5p287.pdf
Abstract
Direct immunofluorescence (DIF) is widely used for the diagnosis of bullous diseases and other autoimmune patho-
logies such as oral lichen planus. There is no evidence in the literature on how the following variants influence the 
detection rate of DIF: intraoral site chosen for the biopsy, perilesional locus or distant site from the clinical lesion, 
number of biopsies and instrument used.
Objectives: to determine if  the following variants influenced the sensitivity (detection rate): intraoral site chosen for 
the biopsy, perilesional or distant site from the clinical lesion, number of biopsies and instrument used (punch or 
scalpel).
Material and methods: A retrospective study was done at the Cátedra de Patología y Clínica Bucodental II at the 
Facultad de Odontología, Universidad de Buenos Aires; 136 clinical medical histories were revised for the period 
March 2000 – March 2005 corresponding to patients with clinical diagnosis of OLP and bullous diseases (vulgar 
pemphigus, bullous pemphigoid and cicatricial pemphigoid).
Results: DIF detection rate was 65.8% in patients with OLP, 66.7% in cicatricial pemphigoid patients, in bullous 
pemphigoid 55.6%, in pemphigus vulgaris 100%, and in those cases in which certain diagnosis could not be obtained, 
the DIF positivity rate was 45.5% (Pearson chi2(4)= 21.5398 Pr= 0.000). There was no statistically significant diffe-
rence between the different sites of biopsy (Fisher exact test: 0.825). DIF detection rate in perilesional biopsies was 
66.1% and in those distant from the site of clinical lesion was 64.7% (Pearson chi2 (1)= 0.0073 Pr= 0.932). When the 
number of biopsies were incremented, DIF detection rate also incremented (Pearson chi2= 8.7247 Pr= 0.003). The 
biopsies taken with punch had a higher detection rate than those taken with scalpel (39.1% versus 71.7%) (Pearson 
chi2= 49.0522 Pr= 0.000).
Conclusion: While not statistically significant, the tendency outlined in this study indicates there are intraoral regions 
in which the detection rate of the DIF technique is higher than others: mouth floor, hard palate, superior labial muco-
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sa, ventral face of tongue. This finding could allow a choice of accessible locations and easy operator manipulation, 
even in distant places from the clinical lesion. Perilesional biopsies have a detection rate similar to those taken distant 
from the clinical lesion, and those taken with punch have a higher sensitivity rate than those taken with scalpel (both 
differences were statistically significant).
Key words: Direct immunofluorescence, oral lichen planus, pemphigus vulgaris, cicatricial pemphigoid, biopsy, sensitivity.
Introduction
The accurate diagnosis of bullous and other immune di-
seases of the skin requires a clinical evaluation, histologic 
and immunofluorescence findings.
Direct immunofluorescence (DIF) use in diagnosis of 
bullous diseases and other immune diseases, such as 
oral lichen planus, has been of great value in confirming 
diagnoses, especially those in subepidermal bullous di-
seases that often have overlap in clinical and histological 
findings.
Direct immunofluorescence (DIF) detects immunoglobu-
lins and complement components within biopsy specimens 
of patient’s tissue. For bullous diseases, DIF is performed 
using perilesional skin or mucosal tissue; for lichen planus, 
vasculitis and connective tissue diseases, lesional skin or 
mucosa is needed. DIF has been used as a diagnostic tool 
for approximately four decades (1- 6). 
Its use has helped the understanding of the physiopatho-
logy of some bullous diseases, making possible gnosologic 
replacements and new classifications (7-10).
Biopsy of lesional tissues for DIF is problematic since 
immune deposits are degraded by intense inflammation or 
damage in the basal membrane zone, rendering the DIF 
falsely negative. Currently, DIF is therefore performed in 
perilesional tissues (2). 
Despite the wide use of this tool, little is known about the 
best anatomic site for taking the sample, especially when 
diseases affect multiple oral regions.
The objective of this study was to determine whether  DIF 
sensitivity (detection rate) was influenced by the following 
variables: oral region chosen for the biopsy, sample taken 
perilesional or from any site  away from the clinical lesion, 
number of  biopsies taken, and whether a punch or a 
scalpel was used.
Material and Methods
We reviewed 136 clinical medical histories of  patients 
who attended our clinic (Cátedra de Clínica y Patología 
Bucodental II, Facultad de Odontología, Universidad de 
Buenos Aires) with oral lichen planus or bullous diseases 
(pemphigus vulgaris, bullous pemphigoid or cicatricial 
pemphigoid), from March 2000 to March 2005.
Inclusion criteria were: bullous diseases and oral lichen 
planus patients of any age and gender, who had a histopa-
thology study and DIF performed. Patients without any 
of these diseases were excluded. If  the site of the biopsy 
for the DIF was not specified in the chart, or there was 
some other concomitant diagnosis such as squamous cell 
carcinoma, candidiasis or leukoplakia, patients were also 
excluded. In 11 cases, histopathology, DIF or clinical 
diagnosis were not concordant, so those charts were also 
excluded; leaving 125 cases for statistical analysis. In 11 
cases of bullous diseases, an accurate diagnosis was not 
possible (non defined cases), for the DIF was negative in 
6 cases, and didn’t match the histology in 5 other cases.
The clinical relevant data taken into account were: age, 
gender, biopsy site, previous medication, histological diag-
nosis and its correlation with the suspected disease (oral 
lichen planus, vulgar pemphigus, bullous pemphigoid, and 
cicatricial pemphigoid).
We considered perilesional biopsies  those taken within a 
radius of 1 cm of the clinical lesion, and distant biopsies 
were those taken outside  this radius.
We also considered whether the biopsy was split in two for 
both studies (histology and DIF) or if  two samples were 
taken separately for each study. The number of biopsies 
taken for DIF was also taken into account.
All biopsies were taken under similar circumstances and 
were analyzed in the same laboratory.
For hematoxylin–eosin staining, samples were first fixed 
in 10% formaldehyde and then stained properly; for DIF, 
samples were embedded in a gaze with saline solution, 
placed in a sterile flask, kept at 3-5 ºC and immediately 
transported to the pathology department, where they 
were processed.
For the DIF technique, 2 micron sections were cut in a 
cryostat at -20ºC and then placed on special slides. The 
sections were then fixed 20 min. in acetone, air-dried and 
afterwards incubated for 24 hours at room temperature 
in 1:15 anti-serum. Slides were then washed thrice; three 
minutes each with a phosphate buffer solution, and moun-
ted afterwards in glycerol-phosphate (1:1) solution. The 
coverslips were sealed with enamel, allowing conservation 
at 3-5ºC until diagnosis.
We considered a positive pattern for vulgar pemphigus 
when Ig M, IgG, IgA or C3 in the intercellular space was 
deposited around the keratinocyte cell surface resulting 
in a honeycomb pattern (11). 
For subepithelial blistering diseases, IgM, IgG, IgA or C3 
deposition along the basal membrane zone in a continuous 
lineal pattern was considered positive, as for lichen planus 
the fibrinogen deposition along the basal membrane zone 
was a continuous shaggy pattern (12) (Figure 1-3).
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Differentiation between bullous pemphigoid and cicatri-
cial pemphigoid was made on clinical grounds, since they 
both share histological and DIF findings and we don’t 
perform immunoblotting in our clinic (13). 
The study was conducted according to the principles 
of  the Helsinki Declaration and its later amendments; 
and in accordance with the International Guidelines for 
Biomedical Investigation in Epidemiological Studies of 
the Council for International Organizations of Medical 
Sciences (CIOMS) and the Habeas Data Law (Protection 
Law of Personal Data).
Method detection rate was calculated as the total positive 
cases over the total occurred cases, and its percentage fre-
quency was expressed regarding type of diagnosis.
In order to determine any association among the analyzed 
categorical variables a Chi square test was performed (14). 
For those cases in which the cross tabs had a cell with an 
expected frequency less than 5, a Fisher’s exact test was 
computed. Any association was considered significant 
when the probability level was less than 0.05.
Results
129 DIF were considered, as some patients had more than 
one DIF performed.
Of the 125 patients, 32 were men and 93 were women. The 
range of ages was 11 to 95 years.
DIF detection rate was 65.8% in patients with oral lichen 
planus, 66.7% in patients with cicatricial pemphigoid, 
55.6% in patients with bullous pemphigoid, and 100% in 
patients with vulgar pemphigus. In those cases with non-
defined certainty diagnosis, DIF positivity was 45.5%. 
As seen in Table 1, there was a significant difference in 
frequency distribution regarding disease type. (Pearson 
chi2 (4L)= 21.5 Pr= 0.000).
Non-statistically significant differences were observed in the 
frequency of DIF positivity regarding different oral sites of 
biopsy sampling. (Fisher exact test: 0.825) (see table 2)
Fig. 3. DIF of bullous pemphigoid.
Fig. 1. DIF of lichen planus.








Oral Lichen Planus 27 52 65,80%




Vulgar Pemphigus 0 9 100%
Non-defined 6 5 45,50%
Table 1. DIF detection rate in different pathologies.







gingiva 3 3 3/6
Dorsal side of tongue 6 10 10/16
Superior vestibular 
gingiva 4 7 7/11
Inferior labial mucosa 2 5 5/7
Superior labial mucosa 1 3 3/4
Ventral side of tongue 1 5 5/6
Alveolar ridge mucosa 1 0 0
Buccal mucosa 22 48 48/70
Hard palate 1 4 4/5
Skin 0 2 2
Mouth floor 0 1 1
Pearson chi2 (4)= 21,5398 Pr=0.000; DIF: direct immunofluorescence.
Table 2. IFD detection rate depending on biopsy site.
Fisher exact test= Pr 0.825.
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DIF positive detection rate in perilesional samples was 
66.1%, whereas in those samples taken in distant sites was 
64.7%. (Pearson chi2 (GL1) = 0.0073 Pr=0.932)
In table 3 we found that detection rate increased signifi-
cantly with increased number of biopsies taken. (Pearson 
chi2 (1GLf)= 8.72 Pr= 0.003).
When punch or scalpel biopsies were compared, we ob-
served that punch samples had a DIF positive detection 
rate statistically greater, being 71.7% as compared to 
39.1% of those taken with scalpel. (Pearson chi2 (1GL)= 
49.05  Pr=0.000)
Discussion
As we can see in Table1, DIF sensitivity depends on the 
analyzed disease, being approximately 66% in OLP and 
cicatricial pemphigoid, and 100% in vulgar pemphigus, 
our results being in coincidence with the world’s literature 
data (15-17). 
As shown in Table 2, oral sites with greater DIF sensitivity 
were in decreasing order, mouth floor, the ventral side of 
the tongue, superior labial mucosa, hard palate and buccal 
mucosa. Oral sites with the least sensitivity were gingiva 
and dorsal side of the tongue. These differences were not 
statistically significant, partially due to the low power of 
the sample. Nevertheless, even though we can not speak 
of a statistically significant difference, we can point out a 
tendency (100% sensitivity in mouth floor or hard palate 
versus 30% in gingiva). 
Making a correct diagnosis in a gingival sample can be 
a technical challenge, and might also leave a periodontal 
defect (18). 
Some authors affirm that the epithelium is frequently 
detached from the chorion underneath or is lost during 
the sample processing, which leads to an incorrect sample 
preparation or to a wrong interpretation (4). 
 Other authors have proposed that gingival sampling 
has a low detection rate for the high degree of unspecific 
inflammation present in that area (13). 
In this sense, we have observed as have other authors, that 
DIF biopsies taken from gingival tissue in general, and in 
several diseases in particular, have a detection rate lower 
than that of other localizations.
Even though it is recommended in the literature that DIF 
biopsies be taken perilesional, our study indicated the 
possibility for greater latitude in tissue sampling. When 
DIF sensitivity was analyzed, there was no significant 
difference between biopsies taken perilesional or distant 
from the clinical lesion.
We know that immune deposit can be present in the whole 
oral tissue, and not only in those localizations near the 
clinical lesions. It is also known, for instance, that even in 
ocular cicatricial pemphigoid cases without clinical oral 
lesions, biopsies for DIF might be taken from oral sites, 
for the immune deposit is also there, and therefore ocular 
morbidity can be avoided (12). 
Presence of immune deposits in the whole oral tissue and 
not only in damaged tissue, might explain our finding that 
DIF was highly positive when biopsies had been taken 
from non-perilesional sites. This gives  more options for 
tissue sampling that might prove useful, especially in cases 
when taking one perilesionally is technically difficult.
From results shown in Table 3, we conclude that splitting 
a biopsy for both hematoxylin-eosin and DIF is not con-
venient, for DIF sensitivity in these cases was significantly 
lower than the rest (40%).
In general, we conclude that there are some anatomic oral 
regions in which the DIF technique sensitivity is greater: 
mouth floor, hard palate, superior labial mucosa, and 
ventral side of the tongue. Knowing this may allow the 
physician to choose accessible and manipulable regions, 
even those that are not close to the clinical lesions.
We can also conclude from this work that punch samples 
have a greater detection rate for DIF than those taken 
with a scalpel.
The results shown in this study need confirmation by a 
randomized, controlled prospective study in order to va-
lidate the tendencies outlined here. This will substantiate 
the usefulness of this approach for improving the diagnosis 
of bullous diseases and OLP using DIF.
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2 14 22 61,10%
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Table 3. IFD detection rate depending on number of 
biopsies.
Pearson chi2 (1)= 8.7247   Pr=0.003
DIF: direct immunofluorescence
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